1
TITLE: GMP-grade nanoparticle targeted to nucleolin downregulates tumor molecular signature, blocking growth and invasion, at low systemic exposure  Full Text
AUTHORS: Fonseca, NA; Gregorio, AC; Mendes, VM; Lopes, R; Abreu, T; Goncalves, N; Manadas, B; Lacerda, M; Figueiredo, P; Pereira, M; Gaspar, M; Colelli, F; Pesce, D; Signorino, G; Focareta, L; Fucci, A; Cardile, F; Pisano, C; Cruz, T; Almeida, L; Moura, V; Simoes, S; Moreira, JN; ...More
PUBLISHED: 2021, SOURCE: NANO TODAY, VOLUME: 37
INDEXED IN: Scopus WOS CrossRef: 17
IN MY: ORCID
2
TITLE: The new feminist frontier on community-based learning: popular feminism, online misogyny, and toxic masculinities  Full Text
AUTHORS: Simoes, PB; Amaral, I; Santos, SJ;
PUBLISHED: 2021, SOURCE: EUROPEAN JOURNAL FOR RESEARCH ON THE EDUCATION AND LEARNING OF ADULTS, VOLUME: 12, ISSUE: 2
INDEXED IN: WOS
3
TITLE: Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives
AUTHORS: Grangeia, HB; Silva, C; Simoes, SP; Reis, MS;
PUBLISHED: 2020, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, VOLUME: 147
INDEXED IN: Scopus WOS CrossRef: 123
IN MY: ORCID
4
TITLE: Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion
AUTHORS: Simões, MF; Pereira, A; Cardoso, S; Cadonau, S; Werner, K; Pinto, RMA; Simões, S;
PUBLISHED: 2020, SOURCE: Molecular Pharmaceutics
INDEXED IN: Scopus CrossRef: 6
IN MY: ORCID
5
TITLE: Artificial neural networks applied to quality-by-design: From formulation development to clinical outcome  Full Text
AUTHORS: Marta F Simoes; Gabriel Silva; Ana C Pinto; Marlene Fonseca; Nuno E Silva; Rui M A Pinto; Sergio Simoes;
PUBLISHED: 2020, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, VOLUME: 152
INDEXED IN: WOS
6
TITLE: Genetic characterization of the CYP2C9, CYP2C19, CYPD6 isoenzymes and P-glycoprotein in portuguese patients with depression  Full Text
AUTHORS: Magalhaes, P; Alves, G; Llerena, A; Fortuna, A; Falcao, A;
PUBLISHED: 2019, SOURCE: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, VOLUME: 41, ISSUE: 1
INDEXED IN: WOS
7
TITLE: Differential effect of liposomal C6-ceramide/doxorubicin targeted to nucleolin and conventional combinations against triple negative
AUTHORS: Ana F Cruz; Nuno A Fonseca; Nelio Goncalves; Vera Moura; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 79, ISSUE: 13
INDEXED IN: WOS
8
TITLE: In vivo targeting of mesothelioma's molecular signature with nanoparticle functionalized with nucleolin-binding peptide
AUTHORS: Fonseca, NA; Moura, V; Colelli, F; Pesce, D; Signorino, G; Focareta, L; Fucci, A; Cardile, F; Pisano, C; Simoes, S; Moreira, JN;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 79, ISSUE: 13
INDEXED IN: WOS CrossRef
IN MY: ORCID
9
TITLE: Abstract 3622: Differential effect of liposomal C6-ceramide/doxorubicin targeted to nucleolin and conventional combinations against triple negative breast cancer stem cells
AUTHORS: Ana F Cruz; Nuno A Fonseca; Nélio Gonçalves; Vera Moura; Sérgio Simões; João Nuno Moreira;
PUBLISHED: 2019, SOURCE: Cancer Research, VOLUME: 79, ISSUE: 13_Supplement
INDEXED IN: CrossRef: 1
IN MY: ORCID
10
TITLE: Meeting the needs of breast cancer: A nucleolin's perspective
AUTHORS: Gregório, AC; Lacerda, M; Figueiredo, P; Simões, S; Dias, S; Moreira, JN;
PUBLISHED: 2018, SOURCE: Critical Reviews in Oncology/Hematology, VOLUME: 125
INDEXED IN: Scopus CrossRef: 33
IN MY: ORCID
Página 1 de 11. Total de resultados: 103.